The purpose of the present study was to analyze the recurrence pattern ofhigh-grade glioma treated with a multimodal treatment approach and to evaluatewhether the MIB-1 labeling index (LI) could be a useful marker for predicting thepattern of failure in glioblastoma (GB). This evidence concerns the gene MIB1 and glioblastoma.